Login / Signup

Statin prescriptions and progression of advanced fibrosis risk in primary care patients with MASLD.

Andrew D SchreinerJingwen ZhangChelsey A PetzWilliam P MoranDavid G KochJustin MarsdenChloe BaysPatrick D MauldinMulugeta Gebregziabher
Published in: BMJ open gastroenterology (2024)
Statin prescriptions, and specifically moderate and high intensity statin prescriptions, demonstrate a protective association with fibrosis risk progression in primary care patients with MASLD.
Keyphrases
  • high intensity
  • primary care
  • cardiovascular disease
  • coronary artery disease
  • resistance training
  • low density lipoprotein
  • general practice
  • type diabetes
  • liver fibrosis